Wegovy in 2021), meaning there isnt a lot of long-term safety data available
Benign semaglutide-related palpitations tend to be brief, not accompanied by chest pain, and not associated with fainting or severe shortness of breath
The CIR (Cosmetic Ingredient Review) panel determined it safe as used in cosmetics at concentrations up to 13%
The company also listed other serious potential side effects, including: Thyroid tumors, including thyroid cancer Pancreatitis (inflammation of the pancreas) Hypoglycemia (low blood sugar) Severe allergic reactions Kidney failure Serious stomach issues Changes in vision These problems have also been associated with Wegovy (semaglutide), produced by Novo Nordisk
Semaglutide also interacts with the brains appetite centers, effectively reducing hunger sensations and cravings
Wamberg CH, Plovsing RR, Sandgaard NCF, Bie P